{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:28:34Z","timestamp":1793039314972,"version":"4.5.0"},"reference-count":117,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Haploidentical stem cell transplantation (haploSCT) has advanced to a common procedure for treating patients with hematological malignancies and immunodeficiency diseases. However, cure is seriously hampered by cytomegalovirus (CMV) infections and delayed immune reconstitution for the majority of haploidentical transplant recipients compared to HLA-matched stem cell transplantation. Three major approaches, including<jats:italic>in vivo<\/jats:italic>T-cell depletion (TCD) using antithymocyte globulin for haploSCT (<jats:italic>in vivo<\/jats:italic>TCD-haploSCT),<jats:italic>ex vivo<\/jats:italic>TCD using CD34\u2009+\u2009positive selection for haploSCT (<jats:italic>ex vivo<\/jats:italic>TCD-haploSCT), and T-cell replete haploSCT using posttransplant cyclophosphamide (PTCy-haploSCT), are currently used worldwide. We provide an update on CMV infection and CMV-specific immune recovery in this fast-evolving field. The progress made in cellular immunotherapy of CMV infection after haploSCT is also addressed. Groundwork has been prepared for the creation of personalized avenues to enhance immune reconstitution and decrease the incidence of CMV infection after haploSCT.<\/jats:p>","DOI":"10.3389\/fimmu.2021.732826","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T04:48:47Z","timestamp":1635396527000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["CMV Infection and CMV-Specific Immune Reconstitution Following Haploidentical Stem Cell Transplantation: An Update"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiao-Hua","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ping","family":"Shui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-2146","article-title":"Conditioning Including Antithymocyte Globulin Followed by Unmanipulated HLA-Mismatched\/Haploidentical Blood and Marrow Transplantation can Achieve Comparable Outcomes With HLA-Identical Sibling Transplantation","volume":"107","author":"Lu","year":"2006","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705445","article-title":"Haploidentical Hematopoietic Stem Cell Transplantation Without In Vitro T-Cell Depletion for the Treatment of Hematological Malignancies","volume":"38","author":"Huang","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0691","article-title":"Partially Matched Related Donor Transplantation can Achieve Outcomes Comparable With Unrelated Donor Transplantation for Patients With Hematologic Malignancies","volume":"15","author":"Xiao-Jun","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27761","article-title":"Long-Term Follow-Up of Haploidentical Hematopoietic Stem Cell Transplantation Without In Vitro T Cell Depletion for the Treatment of Leukemia","volume":"119","author":"Wang","year":"2013","journal-title":"Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2015.12.003","article-title":"Risk Factors for Cytomegalovirus DNAemia Following Haploidentical Stem Cell Transplantation and Its Association With Host Hepatitis B Virus Serostatus","volume":"75","author":"Chen","year":"2016","journal-title":"J Clin Virol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0790-z","article-title":"Incidence, Risk Factors, and Outcomes of Cytomegalovirus Retinitis After Haploidentical Hematopoietic Stem Cell Transplantation","volume":"55","author":"Yan","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04201-4","article-title":"Comparison of Different Cytomegalovirus Diseases Following Haploidentical Hematopoietic Stem Cell Transplantation","volume":"99","author":"Meng","year":"2020","journal-title":"Ann Hematol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit475","article-title":"High Rate of Cytomegalovirus Drug Resistance Among Patients Receiving Preemptive Antiviral Treatment After Haploidentical Stem Cell Transplantation","volume":"209","author":"Shmueli","year":"2014","journal-title":"J Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14225","article-title":"Haplo-Identical Transplantation for Acquired Severe Aplastic Anaemia in a Multicentre Prospective Study","volume":"175","author":"Xu","year":"2016","journal-title":"Br J Haematol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-017-0398-y","article-title":"Upfront Haploidentical Transplant for Acquired Severe Aplastic Anemia: Registry-Based Comparison With Matched Related Transplant","volume":"10","author":"Xu","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2017.237","article-title":"Unmanipulated Haploidentical Transplantation Conditioning With Busulfan, Cyclophosphamide and Anti-Thymoglobulin for Adult Severe Aplastic Anaemia","volume":"53","author":"Xu","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.281","article-title":"Haploidentical Transplantation for Pediatric Patients With Acquired Severe Aplastic Anemia","volume":"52","author":"Xu","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.05.015","article-title":"Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia","volume":"24","author":"Lu","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.187","article-title":"Good Outcome of Haploidentical Hematopoietic SCT as a Salvage Therapy in Children and Adolescents With Acquired Severe Aplastic Anemia","volume":"49","author":"Wang","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2013.224","article-title":"Long-Term Outcome of HLA-Haploidentical Hematopoietic SCT Without In Vitro T-Cell Depletion for Adult Severe Aplastic Anemia After Modified Conditioning and Supportive Therapy","volume":"49","author":"Gao","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04355-1","article-title":"Comparable Outcomes Among Unmanipulated Haploidentical, Matched Unrelated, and Matched Sibling Donors in BU-Based Myeloablative Hematopoietic Stem Cell Transplantation for Intermediate and Adverse Risk Acute Myeloid Leukemia in Complete Remission: A Single-Center Study","volume":"100","author":"Lu","year":"2021","journal-title":"Ann Hematol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3290","article-title":"Haploidentical Related Donor vs Matched Sibling Donor Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome Aged Over 50 Years: A Single-Center Retrospective Study","volume":"9","author":"Huang","year":"2020","journal-title":"Cancer Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-015-0186-5","article-title":"Favorable Outcome of Haploidentical Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Multicenter Study in Southwest China","volume":"8","author":"Gao","year":"2015","journal-title":"J Hematol Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2017.229","article-title":"Myeloablative Conditioning Regimens With Combined of Haploidentical and Cord Blood Transplantation for Myelodysplastic Syndrome Patients","volume":"53","author":"Ke","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e13864","DOI":"10.1111\/petr.13864","article-title":"Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation for Children With Myelodysplastic Syndrome","volume":"24","author":"Suo","year":"2020","journal-title":"Pediatr Transplant"},{"key":"B21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13045-020-00873-7","article-title":"Pre-Transplant MRD Negativity Predicts Favorable Outcomes of CAR-T Therapy Followed by Haploidentical HSCT for Relapsed\/Refractory Acute Lymphoblastic Leukemia: A Multi-Center Retrospective Study","volume":"13","author":"Zhao","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-571570","article-title":"T-Cell-Replete Haploidentical HSCT With Low-Dose Anti-T-Lymphocyte Globulin Compared With Matched Sibling HSCT and Unrelated HSCT","volume":"124","author":"Luo","year":"2014","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.166","article-title":"Haploidentical, Unmanipulated G-CSF-Primed Peripheral Blood Stem Cell Transplantation for High-Risk Hematologic Malignancies: An Update","volume":"51","author":"Huang","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0874-9","article-title":"Combination of Haploidentical Haematopoietic Stem Cell Transplantation With an Unrelated Cord-Blood Unit in Patients With Severe Aplastic Anemia: A Report of 146 Cases","volume":"55","author":"Liu","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0666-2","article-title":"Haploidentical Stem Cells Combined With a Small Dose of Umbilical Cord Blood Transplantation Exert Similar Survival Outcome of HLA-Matched Stem Cells Transplantation in T-Cell Acute Lymphoblastic Leukemia","volume":"55","author":"Xu","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.09.002","article-title":"Cord Haploidentical Non-In Vitro T Cell Depletion Allogeneic Hematopoietic Stem Cell Transplantation Reduces Relapse of Refractory Acute Leukemia","volume":"25","author":"Wang","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.347","article-title":"Cotransplantation of Bone Marrow-Derived Mesenchymal Stem Cells in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: An Interim Summary for a Multicenter Phase II Trial Results","volume":"52","author":"Liu","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.939970","article-title":"Haploidentical Hematopoietic Stem Cell Transplant With Umbilical Cord-Derived Multipotent Mesenchymal Cell Infusion for the Treatment of High-Risk Acute Leukemia in Children","volume":"56","author":"Zhu","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04156-6","article-title":"Risk Factors and Associations With Clinical Outcomes of Cytomegalovirus Reactivation After Haploidentical Versus Matched-Sibling Unmanipulated PBSCT in Patients With Hematologic Malignancies","volume":"99","author":"Gao","year":"2020","journal-title":"Ann Hematol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/bjh.14331","article-title":"Similar Incidence of Severe Acute GVHD and Less Severe Chronic GVHD in PBSCT From Unmanipulated, Haploidentical Donors Compared With That From Matched Sibling Donors for Patients With Haematological Malignancies","volume":"176","author":"Li","year":"2017","journal-title":"Br J Haematol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2013.191","article-title":"Influence of Two Different Doses of Antithymocyte Globulin in Patients With Standard-Risk Disease Following Haploidentical Transplantation: A Randomized Trial","volume":"49","author":"Wang","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"B32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12916-019-1393-7","article-title":"Two Dose Levels of Rabbit Antithymocyte Globulin as Graft-Versus-Host Disease Prophylaxis in Haploidentical Stem Cell Transplantation: A Multicenter Randomized Study","volume":"17","author":"Lin","year":"2019","journal-title":"BMC Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.scib.2021.06.002","article-title":"Optimizing Antithymocyte Globulin Dosing in Haploidentical Hematopoietic Cell Transplantation: Long-Term Follow-Up of a Multicenter, Randomized Controlled Trial","author":"Wang","year":"2021","journal-title":"Sci Bull"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1080\/10245332.2016.1231968","article-title":"HLA-Mismatched Haploidentical Transplantation Using Low-Dose Anti-Thymocyte Globulin (ATG: Thymoglobulin)","volume":"22","author":"Kako","year":"2017","journal-title":"Hematology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/tan.13966","article-title":"Specific Donor HLA Allotypes as Predictors of Cytomegalovirus Disease Risk in Acute Myeloid Leukemia","volume":"96","author":"Min","year":"2020","journal-title":"Hla"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000003342","article-title":"Comparable Outcomes Between Unrelated and Haploidentical Stem Cell Transplantation in Adult Patients With Severe Aplastic Anemia","volume":"105","author":"Park","year":"2021","journal-title":"Transplantation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.leukres.2017.02.006","article-title":"Low Incidence of Acute Graft-Versus-Host Disease With Short-Term Tacrolimus in Haploidentical Hematopoietic Stem Cell Transplantation","volume":"57","author":"Gao","year":"2017","journal-title":"Leuk Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.09.017","article-title":"A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation","volume":"22","author":"Gaballa","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1080\/10245332.2016.1238182","article-title":"Tcr\u03b1\u03b2-Depleted Haploidentical Transplantation Results in Adult Acute Leukemia Patients","volume":"22","author":"Kaynar","year":"2017","journal-title":"Hematology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e13192","DOI":"10.1111\/petr.13192","article-title":"Comparison of Outcomes After HLA-Matched Unrelated and \u03b1\u03b2 T-Cell-Depleted Haploidentical Hematopoietic Stem Cell Transplantation for Children With High-Risk Acute Leukemia","volume":"22","author":"Erbey","year":"2018","journal-title":"Pediatr Transplant"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-01020-z","article-title":"The Role of Interim-Foscarnet Prophylaxis in Preventing Cytomegalovirus Infection After Ex Vivo \u03b1\u03b2 T Cell-Depleted Haploidentical Hematopoietic Cell Transplant in Children","volume":"56","author":"Kang","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-Haploidentical Stem Cell Transplantation After Removal of \u03b1\u03b2+ T and B Cells in Children With Nonmalignant Disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e13517","DOI":"10.1111\/petr.13517","article-title":"TCR \u03b1+\u03b2+\/CD19+ Cell\u2013Depleted Hematopoietic Stem Cell Transplantation for Pediatric Patients","volume":"23","author":"Mitchell","year":"2019","journal-title":"Pediatr Transplant"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-599423","article-title":"\u03b3\u03b4 T-Cell Reconstitution After HLA-Haploidentical Hematopoietic Transplantation Depleted of TCR-\u03b1\u03b2+\/CD19+ Lymphocytes","volume":"125","author":"Airoldi","year":"2015","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.02.014","article-title":"T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Familial Hemophagocytic Lymphohistiocytosis Who Do Not Have Matched Family Donors: Experience in Oman","volume":"26","author":"Nazir","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B46","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41409-019-0608-z","article-title":"Haploidentical Hematopoietic Stem Cell Transplantation in Adults Using the \u03b1\u03b2tcr\/CD19-Based Depletion of G-CSF-Mobilized Peripheral Blood Progenitor Cells","volume":"54","author":"Prezioso","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017012005","article-title":"Haploidentical HSCT for Hemoglobinopathies: Improved Outcomes With Tcr\u03b1\u03b2(+)\/CD19(+)-Depleted Grafts","volume":"2","author":"Gaziev","year":"2018","journal-title":"Blood Adv"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1172\/JCI81229","article-title":"Outcomes of Acute Leukemia Patients Transplanted With Naive T Cell\u2013Depleted Stem Cell Grafts","volume":"125","author":"Bleakley","year":"2015","journal-title":"J Clin Invest"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.324","article-title":"Rapid Memory T-Cell Reconstitution Recapitulating CD45RA-Depleted Haploidentical Transplant Graft Content in Patients With Hematologic Malignancies","volume":"50","author":"Triplett","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e12823","DOI":"10.1111\/tid.12823","article-title":"Selective T-Cell Depletion Targeting CD45RA Reduces Viremia and Enhances Early T-Cell Recovery Compared With CD3-Targeted T-Cell Depletion","volume":"20","author":"Triplett","year":"2018","journal-title":"Transplant Infect Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009362","article-title":"Posttransplant Cyclophosphamide Is Associated With Increased Cytomegalovirus Infection: A CIBMTR Analysis","volume":"137","author":"Goldsmith","year":"2021","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0475-7","article-title":"Evaluation of Infectious Complications After Haploidentical Hematopoietic Stem Cell Transplantation With Post-Transplant Cyclophosphamide Following Reduced-Intensity and Myeloablative Conditioning: A Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-Tc)","volume":"54","author":"Fayard","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12365","article-title":"Infections After T-Replete Haploidentical Transplantation and High-Dose Cyclophosphamide as Graft-Versus-Host Disease Prophylaxis","volume":"17","author":"Crocchiolo","year":"2015","journal-title":"Transplant Infect Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01328-4","article-title":"Severe Infections and Infection-Related Mortality in a Large Series of Haploidentical Hematopoietic Stem Cell Transplantation With Post-Transplant Cyclophosphamide","volume":"56","author":"Esquirol","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e13206","DOI":"10.1111\/tid.13206","article-title":"Incidence, Features, and Outcomes of Cytomegalovirus DNAemia in Unmanipulated Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-Transplantation Cyclophosphamide","volume":"22","author":"Huntley","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.69","article-title":"The Patient\u2019s CMV Serological Status Affects Clinical Outcome After T-Cell Replete Haplo-HSCT and Post-Transplant Cyclophosphamide","volume":"51","author":"Crocchiolo","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V130.Suppl_1.4494.4494","article-title":"High Incidence of CMV Reactivation After Haploidentical Donor Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide, and Its Impact on Transplant Outcomes","volume":"130","author":"Al Malki","year":"2017","journal-title":"Blood"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0865-x","article-title":"Reconstitution of Cytomegalovirus-Specific T-Cell Immunity Following Unmanipulated Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Posttransplant Cyclophosphamide","volume":"55","author":"Huntley","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-01092-x","article-title":"Patterns of Infection and Infectious-Related Mortality in Patients Receiving Post-Transplant High Dose Cyclophosphamide as Graft-Versus-Host-Disease Prophylaxis: Impact of HLA Donor Matching","volume":"56","author":"Irene","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.09.018","article-title":"Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell Transplantation","volume":"24","author":"Hammerstrom","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-00600-z","article-title":"Haploidentical Stem Cell Transplantation With Post-Transplant Cyclophosphamide for Primary Immune Deficiency Disorders in Children: Challenges and Outcome From a Tertiary Care Center in South India","volume":"39","author":"Uppuluri","year":"2019","journal-title":"J Clin Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.09.007","article-title":"Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes After Haploidentical Donor Hematopoietic Stem Cell Transplantation With Post-Transplantation Cyclophosphamide for Relapsed\/Refractory Severe Aplastic Anemia","volume":"26","author":"Arcuri","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.216","article-title":"Impact of Haploidentical Hematopoietic Cell Transplantation Conditioning Intensity on the Incidence and Severity of Post-Transplantation Viral Infections","volume":"51","author":"Raj","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.20","article-title":"Progressive Substitution of Posttransplant Cyclophosphamide With Bendamustine: A Phase I Study in Haploidentical Bone Marrow Transplantation","volume":"1","author":"Katsanis","year":"2020","journal-title":"eJHaem"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.149880","article-title":"Cytomegalovirus Viremia, Disease, and Impact on Relapse in T-Cell Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide","volume":"101","author":"Goldsmith","year":"2016","journal-title":"Haematologica"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.03.003","article-title":"Total Body Irradiation\u2013Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors","volume":"21","author":"Solomon","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e1171","DOI":"10.1002\/cti2.1171","article-title":"High-Dose Post-Transplant Cyclophosphamide Impairs \u03b3\u03b4 T-Cell Reconstitution After Haploidentical Haematopoietic Stem Cell Transplantation Using Low-Dose Antithymocyte Globulin and Peripheral Blood Stem Cell Graft","volume":"9","author":"Stocker","year":"2020","journal-title":"Clin Trans Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.01.013","article-title":"Infections After Allogenic Transplant With Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching","volume":"26","author":"Oltolini","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e12629","DOI":"10.1111\/tid.12629","article-title":"Epidemiology of Infections Following Haploidentical Peripheral Blood Hematopoietic Cell Transplantation","volume":"19","author":"Slade","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0921-6","article-title":"Uniform Graft-Versus-Host Disease Prophylaxis With Posttransplant Cyclophosphamide, Sirolimus, and Mycophenolate Mofetil Following Hematopoietic Stem Cell Transplantation From Haploidentical, Matched Sibling and Unrelated Donors","volume":"55","author":"Montoro","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.04.025","article-title":"Post-Transplantation Cyclophosphamide and Sirolimus After Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-Based Myeloablative Conditioning and Peripheral Blood Stem Cells","volume":"21","author":"Cieri","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.07.008","article-title":"Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression With Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-Versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies","volume":"24","author":"Law","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0813-9","article-title":"Dual T-Cell Depletion With ATG and PTCy for Peripheral Blood Reduced Intensity Conditioning Allo-HSCT Results in Very Low Rates of GVHD","volume":"55","author":"Salas","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13321","article-title":"Reduced Intensity Allogeneic Stem Cell Transplant With Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide in Acute Myeloid Leukemia","volume":"103","author":"Salas","year":"2019","journal-title":"Eur J Haematol"},{"key":"B75","doi-asserted-by":"crossref","first-page":"e13096","DOI":"10.1111\/tid.13096","article-title":"Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation Increases the Risk of Cytomegalovirus Infection in adult Patients With Acute Leukemia","volume":"21","author":"Lint","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e1356152","DOI":"10.1080\/2162402X.2017.1356152","article-title":"Low-Dose Post-Transplant Cyclophosphamide can Mitigate GVHD and Enhance the G-CSF\/ATG Induced GVHD Protective Activity and Improve Haploidentical Transplant Outcomes","volume":"6","author":"Wang","year":"2017","journal-title":"OncoImmunology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13045-019-0781-y","article-title":"Low-Dose Post-Transplant Cyclophosphamide and Anti-Thymocyte Globulin as an Effective Strategy for GVHD Prevention in Haploidentical Patients","volume":"12","author":"Wang","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2423-y","article-title":"Virus Infection in HLA-Haploidentical Hematopoietic Stem Cell Transplantation: Incidence in the Context of Immune Recovery in Two Different Transplantation Settings","volume":"94","author":"Tischer","year":"2015","journal-title":"Ann Hematol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0897-2","article-title":"Haploidentical Hematopoietic Stem Cell Transplantation in Aplastic Anemia: A Systematic Review and Meta-Analysis of Clinical Outcome on Behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation (SAAWP of EBMT)","volume":"55","author":"ElGohary","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-016-2873-8","article-title":"Baseline Antibody Level may Help Predict the Risk of Active Human Cytomegalovirus Infection in a HCMV Seropositive Population","volume":"36","author":"Li","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B81","article-title":"Seroprevalence of CMV Antibodies in a Blood Donor Population and Premature Neonates in the South-Central Taiwan","volume":"15","author":"Lu","year":"1999","journal-title":"Kaohsiung J Med Sci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e2034","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the Worldwide Seroprevalence of Cytomegalovirus: A Systematic Review and Meta-Analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev Med Virol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e0200267","DOI":"10.1371\/journal.pone.0200267","article-title":"Cytomegalovirus (CMV) Seroprevalence in the Adult Population of Germany","volume":"13","author":"Lachmann","year":"2018","journal-title":"PloS One"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268817000103","article-title":"Seroprevalence of Cytomegalovirus Infection in France in 2010","volume":"145","author":"Antona","year":"2017","journal-title":"Epidemiol Infect"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/631951","article-title":"Improving Cytomegalovirus-Specific T Cell Reconstitution After Haploidentical Stem Cell Transplantation","volume":"2014","author":"Luo","year":"2014","journal-title":"J Immunol Res"},{"key":"B86","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1399-3062.2012.00722.x","article-title":"Immune Reconstitution to Cytomegalovirus Following Partially Matched-Related Donor Transplantation: Impact of In Vivo T-Cell Depletion and Granulocyte Colony-Stimulating Factor-Primed Peripheral Blood\/Bone Marrow Mixed Grafts","volume":"15","author":"Luo","year":"2013","journal-title":"Transplant Infect Dis"},{"key":"B87","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.bbmt.2010.02.007","article-title":"Protective Immunity Transferred by Infusion of Cytomegalovirus-Specific CD8+ T Cells Within Donor Grafts: Its Associations With Cytomegalovirus Reactivation Following Unmanipulated Allogeneic Hematopoietic Stem Cell Transplantation","volume":"16","author":"Luo","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2446-4","article-title":"Early Detection of Cytomegalovirus-Specific Cytotoxic T Lymphocytes Against Cytomegalovirus Antigenemia in Human Leukocyte Antigen Haploidentical Hematopoietic Stem Cell Transplantation","volume":"94","author":"Kato","year":"2015","journal-title":"Ann Hematol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.132","article-title":"Early Recovery of CMV Immunity After HLA-Haploidentical Hematopoietic Stem Cell Transplantation as a Surrogate Biomarker for a Reduced Risk of Severe Infections Overall","volume":"50","author":"Noviello","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0950-1","article-title":"Peripheral Blood Regulatory T Cells and Occurrence of Cytomegalovirus DNAemia After Unmanipulated Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Posttransplant Cyclophosphamide","volume":"55","author":"Huntley","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.276352","article-title":"Single-Cell Profiling Reveals the Dynamics of Cytomegalovirusspecific T-Cells in Haploidentical Hematopoietic Stem Cell Transplantation","volume":"106","author":"van Beek","year":"2021","journal-title":"Haematologica"},{"key":"B92","doi-asserted-by":"publisher","first-page":"51","DOI":"10.18632\/oncotarget.13916","article-title":"Characterization of Ifn\u03b3-Producing Natural Killer Cells Induced by Cytomegalovirus Reactivation After Haploidentical Hematopoietic Stem Cell Transplantation","volume":"8","author":"Jin","year":"2017","journal-title":"Oncotarget"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.06.008","article-title":"Early Cytomegalovirus Reactivation and Expansion of CD56(bright)CD16(dim\/-)DNAM1(+) Natural Killer Cells Are Associated With Antileukemia Effect After Haploidentical Stem Cell Transplantation in Acute Leukemia","volume":"25","author":"Jang","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.134155","article-title":"Analysis of Memory-Like Natural Killer Cells in Human Cytomegalovirus-Infected Children Undergoing \u03b1\u03b2+T and B Cell-Depleted Hematopoietic Stem Cell Transplantation for Hematological Malignancies","volume":"101","author":"Muccio","year":"2016","journal-title":"Haematologica"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14622","article-title":"Recipient-Donor KIR Ligand Matching Prevents CMV Reactivation Post-Haploidentical T Cell-Replete Transplantation","volume":"177","author":"Zhao","year":"2017","journal-title":"Br J Haematol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-018-9565-5","article-title":"NK Cell Reconstitution Following Unmanipulated HLA-Mismatched\/Haploidentical Transplantation Compared With Matched Sibling Transplantation","volume":"63","author":"Hu","year":"2020","journal-title":"Sci China Life Sci"},{"key":"B97","doi-asserted-by":"publisher","first-page":"e146973","DOI":"10.1172\/jci.insight.146973","article-title":"Single-Cell Profiling Identifies Impaired Adaptive NK Cells Expanded After HCMV Reactivation in Haploidentical-HSCT","volume":"6","author":"Zaghi","year":"2021","journal-title":"JCI Insight"},{"key":"B98","doi-asserted-by":"publisher","first-page":"e13147","DOI":"10.1111\/ctr.13147","article-title":"Reconstitution of T and NK Cells After Haploidentical Hematopoietic Cell Transplantation Using \u03b1\u03b2 T Cell-Depleted Grafts and the Clinical Implication of \u03b3\u03b4 T Cells","volume":"32","author":"Park","year":"2018","journal-title":"Clin Transplant"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive Transfer of Pp65-Specific T Cells for the Treatment of Chemorefractory Cytomegalovirus Disease or Reactivation After Haploidentical and Matched Unrelated Stem Cell Transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix357","article-title":"Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus","volume":"216","author":"Pei","year":"2017","journal-title":"J Infect Dis"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz368","article-title":"First-Line Therapy With Donor-Derived Human Cytomegalovirus (HCMV)\u2013specific T Cells Reduces Persistent HCMV Infection by Promoting Antiviral Immunity After Allogenic Stem Cell Transplantation","volume":"70","author":"Zhao","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2019.1710945","article-title":"Donor CMV-Specific Cytotoxic T Lymphocytes Successfully Treated Drug-Resistant Cytomegalovirus Encephalitis After Allogeneic Hematopoietic Stem Cell Transplantation","volume":"25","author":"Ke","year":"2020","journal-title":"Hematology"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-017-0035-y","article-title":"Low-Dose Donor Memory T-Cell Infusion After TCR Alpha\/Beta Depleted Unrelated and Haploidentical Transplantation: Results of a Pilot Trial","volume":"53","author":"Maschan","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01232-x","article-title":"Safety and Efficacy of the Low-Dose Memory (CD45RA-Depleted) Donor Lymphocyte Infusion in Recipients of \u03b1\u03b2 T Cell-Depleted Haploidentical Grafts: Results of a Prospective Randomized Trial in High-Risk Childhood Leukemia","volume":"56","author":"Dunaikina","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.01.010","article-title":"Serotherapy-Free Regimen Improves Non-Relapse Mortality and Immune Recovery Among the Recipients of \u03b1\u03b2 TCell\u2013Depleted Haploidentical Grafts: Retrospective Study in Childhood Leukemia","volume":"27","author":"Shelikhova","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.03.010","article-title":"Feasibility and Efficacy of CD45RA+ Depleted Donor Lymphocytes Infusion After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Patients With Hematological Malignancies","volume":"27","author":"Castagna","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0685-z","article-title":"Successful Treatment of Refractory CMV Colitis After Haploidentical HSCT With Post-Transplant Cyclophosphamide Using CD45RA+ Depleted Donor Lymphocyte Infusion","volume":"55","author":"Park","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B108","doi-asserted-by":"publisher","first-page":"e13882","DOI":"10.1111\/petr.13882","article-title":"Use of Low Cell Dose for Unmanipulated Donor Lymphocyte for Management of Cytomegalovirus Infection: A Single-Center Experience","volume":"24","author":"Uygun","year":"2020","journal-title":"Pediatr Transplant"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.01.018","article-title":"Early Cytomegalovirus Reactivation Leaves a Specific and Dynamic Imprint on the Reconstituting T Cell Compartment Long-Term After Hematopoietic Stem Cell Transplantation","volume":"20","author":"Lugthart","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.113415","article-title":"Cytomegalovirus Shapes Long-Term Immune Reconstitution After Allogeneic Stem Cell Transplantation","volume":"100","author":"Raphael","year":"2015","journal-title":"Haematologica"},{"key":"B111","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/imm.12991","article-title":"The Impact of Inflationary Cytomegalovirus-Specific Memory T Cells on Anti-Tumour Immune Responses in Patients With Cancer","volume":"155","author":"Luo","year":"2018","journal-title":"Immunology"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3585-1","article-title":"Cytomegalovirus Infection is Associated With AML Relapse After Allo-HSCT: A Meta-Analysis of Observational Studies","volume":"98","author":"Zhang","year":"2019","journal-title":"Ann Hematol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-304121","article-title":"Early Human Cytomegalovirus Replication After Transplantation is Associated With a Decreased Relapse Risk: Evidence for a Putative Virus-Versus-Leukemia Effect in Acute Myeloid Leukemia Patients","volume":"118","author":"Elmaagacli","year":"2011","journal-title":"Blood"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-487074","article-title":"CMV Reactivation After Allogeneic HCT and Relapse Risk: Evidence for Early Protection in Acute Myeloid Leukemia","volume":"122","author":"Green","year":"2013","journal-title":"Blood J Am Soc Hematol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-679639","article-title":"Early Cytomegalovirus Reactivation Remains Associated With Increased Transplant-Related Mortality in the Current Era: A CIBMTR Analysis","volume":"127","author":"Teira","year":"2016","journal-title":"Blood"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.03.020","article-title":"Evidence for a Bidirectional Relationship Between Cytomegalovirus Replication and Acute Graft-Versus-Host Disease","volume":"16","author":"Cantoni","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198411000-00004","article-title":"Cytomegalovirus Infection Associated With and Preceding Chronic Graft-Versus-Host Disease","volume":"38","author":"L\u00f6nnqvist","year":"1984","journal-title":"Transplantation"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.732826\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T21:15:47Z","timestamp":1699737347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.732826\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":117,"alternative-id":["10.3389\/fimmu.2021.732826"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.732826","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,28]]},"article-number":"732826"}}